Literature DB >> 3015727

Oligodeoxynucleotide-directed mutagenesis using the yeast transformation system.

R Y Walder, J A Walder.   

Abstract

In this report we describe a highly efficient method for site-specific mutagenesis using the yeast transformation system. The method is based on the observation that Saccharomyces cerevisiae can be transformed at high frequency with single-stranded circular DNA vectors [Singh et al., Gene 20 (1982) 441-449]. The model system studied was the TRP1 gene of S. cerevisiae cloned into a derivative of the phage M13mp9 vector containing the yeast URA3 gene. ARS1, located adjacent to the TRP1 gene, allows the plasmid to replicate autonomously in yeast. Synthetic 5'P-oligodeoxynucleotides, 19 and 35 nucleotides (nt) in length, designed to produce an A----T transversion mutation within the TRP1 gene, were annealed to ss DNA of the M13 vector at a molar ratio of 30:1 and directly transformed into yeast. The intended single nt mutation was obtained at frequencies of 24 and 43%, respectively. The latter approaches the theoretical limit of 50%. In the absence of the 5'-terminal phosphate, both the transformation frequency and the efficiency of mutagenesis by the synthetic oligodeoxynucleotide (oligo) were decreased by 2-4 fold. This procedure completely obviates the need for any enzymatic manipulations in vitro after forming the heteroduplex with the oligo primer containing the desired mutation. For yeast genes, direct phenotypic selection is possible in the recipient strain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015727     DOI: 10.1016/0378-1119(86)90289-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Transformation of yeast with synthetic oligonucleotides.

Authors:  R P Moerschell; S Tsunasawa; F Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  A simple and highly efficient procedure for rescuing autonomous plasmids from yeast.

Authors:  K Robzyk; Y Kassir
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

3.  Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.

Authors:  B M Curtis; D E Williams; H E Broxmeyer; J Dunn; T Farrah; E Jeffery; W Clevenger; P deRoos; U Martin; D Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Efficient homologous recombination of Ty1 element cDNA when integration is blocked.

Authors:  G Sharon; T J Burkett; D J Garfinkel
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

5.  In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides.

Authors:  L Liu; M C Rice; E B Kmiec
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

6.  Molecular genetic studies of the Cdc7 protein kinase and induced mutagenesis in yeast.

Authors:  R E Hollingsworth; R M Ostroff; M B Klein; L A Niswander; R A Sclafani
Journal:  Genetics       Date:  1992-09       Impact factor: 4.562

7.  Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

Authors:  R G Goodwin; S Lupton; A Schmierer; K J Hjerrild; R Jerzy; W Clevenger; S Gillis; D Cosman; A E Namen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  Characterization of nuclear localizing sequences derived from yeast ribosomal protein L29.

Authors:  M R Underwood; H M Fried
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

9.  A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells.

Authors:  Natalia Rivera-Torres; Eric B Kmiec
Journal:  J Vis Exp       Date:  2017-08-25       Impact factor: 1.355

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.